pharmaobservatory 0.1.6 → 0.1.8

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (455) hide show
  1. checksums.yaml +4 -4
  2. data/README.md +348 -4
  3. data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
  4. data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
  5. data/docs/BiomarkerAssayProvidersResponse.md +58 -0
  6. data/docs/BiomarkerAssayProvidersRow.md +72 -0
  7. data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
  8. data/docs/BiomarkerEvidenceByYearRow.md +32 -0
  9. data/docs/BiomarkerTraversalStatusResponse.md +58 -0
  10. data/docs/BiomarkerTraversalStatusRow.md +36 -0
  11. data/docs/BiomarkersApi.md +320 -0
  12. data/docs/BrandCompaniesResponse.md +58 -0
  13. data/docs/BrandCompaniesRow.md +50 -0
  14. data/docs/BrandRevenueResponse.md +58 -0
  15. data/docs/BrandRevenueRow.md +60 -0
  16. data/docs/CatalystsResponse.md +58 -0
  17. data/docs/CatalystsRow.md +90 -0
  18. data/docs/CliaCertificatesResponse.md +58 -0
  19. data/docs/CliaCertificatesRow.md +80 -0
  20. data/docs/CompaniesApi.md +2656 -196
  21. data/docs/CompaniesRecordAttributes.md +3 -1
  22. data/docs/CompanyAssetsRow.md +5 -1
  23. data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
  24. data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
  25. data/docs/CompanyFundingEventsRow.md +2 -0
  26. data/docs/CompanyProgramsRow.md +5 -1
  27. data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
  28. data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
  29. data/docs/CompanyTrialGeographyResponse.md +58 -0
  30. data/docs/CompanyTrialGeographyRow.md +52 -0
  31. data/docs/CompanyTrialSitesResponse.md +58 -0
  32. data/docs/CompanyTrialSitesRow.md +52 -0
  33. data/docs/ConditionsApi.md +320 -0
  34. data/docs/CroFootprintResponse.md +58 -0
  35. data/docs/CroFootprintRow.md +34 -0
  36. data/docs/CroTrialsResponse.md +58 -0
  37. data/docs/CroTrialsRow.md +46 -0
  38. data/docs/DebarmentsResponse.md +58 -0
  39. data/docs/DebarmentsRow.md +44 -0
  40. data/docs/DrugApprovalsResponse.md +58 -0
  41. data/docs/DrugApprovalsRow.md +28 -0
  42. data/docs/DrugAspCodesResponse.md +58 -0
  43. data/docs/DrugAspCodesRow.md +28 -0
  44. data/docs/DrugBrandsResponse.md +58 -0
  45. data/docs/DrugBrandsRow.md +60 -0
  46. data/docs/DrugCombinationsResponse.md +58 -0
  47. data/docs/DrugCombinationsRow.md +32 -0
  48. data/docs/DrugDeclaredPatentsResponse.md +58 -0
  49. data/docs/DrugDeclaredPatentsRow.md +58 -0
  50. data/docs/DrugLabelSafetyResponse.md +58 -0
  51. data/docs/DrugLabelSafetyRow.md +32 -0
  52. data/docs/DrugMedicareSpendResponse.md +58 -0
  53. data/docs/DrugMedicareSpendRow.md +28 -0
  54. data/docs/DrugPatentCliffRow.md +3 -1
  55. data/docs/DrugPatentMentionsResponse.md +58 -0
  56. data/docs/DrugPatentMentionsRow.md +28 -0
  57. data/docs/DrugPatentOwnersResponse.md +58 -0
  58. data/docs/DrugPatentOwnersRow.md +42 -0
  59. data/docs/DrugPricingResponse.md +58 -0
  60. data/docs/DrugPricingRow.md +32 -0
  61. data/docs/DrugRecallsResponse.md +58 -0
  62. data/docs/DrugRecallsRow.md +34 -0
  63. data/docs/DrugRegulatoryResponse.md +58 -0
  64. data/docs/DrugRegulatoryRow.md +38 -0
  65. data/docs/DrugSitesResponse.md +58 -0
  66. data/docs/DrugSitesRow.md +28 -0
  67. data/docs/DrugTargetsResponse.md +58 -0
  68. data/docs/DrugTargetsRow.md +36 -0
  69. data/docs/DrugTrialConditionsResponse.md +58 -0
  70. data/docs/DrugTrialConditionsRow.md +30 -0
  71. data/docs/DrugTrialsResponse.md +58 -0
  72. data/docs/DrugTrialsRow.md +58 -0
  73. data/docs/DrugVariantsResponse.md +58 -0
  74. data/docs/DrugVariantsRow.md +38 -0
  75. data/docs/DrugsApi.md +2153 -0
  76. data/docs/DrugsRecord.md +38 -0
  77. data/docs/DrugsRecordAttributes.md +20 -0
  78. data/docs/DrugsResponse.md +58 -0
  79. data/docs/DrugsRow.md +82 -0
  80. data/docs/EnforcementEventsResponse.md +58 -0
  81. data/docs/EnforcementEventsRow.md +64 -0
  82. data/docs/GxpFacilitiesResponse.md +58 -0
  83. data/docs/GxpFacilitiesRow.md +174 -0
  84. data/docs/HospitalBedsYearlyResponse.md +58 -0
  85. data/docs/HospitalBedsYearlyRow.md +28 -0
  86. data/docs/HospitalFacilityChangesResponse.md +58 -0
  87. data/docs/HospitalFacilityChangesRow.md +30 -0
  88. data/docs/HospitalsApi.md +393 -0
  89. data/docs/HospitalsRecord.md +38 -0
  90. data/docs/HospitalsResponse.md +58 -0
  91. data/docs/HospitalsRow.md +40 -0
  92. data/docs/ImportRefusalsResponse.md +58 -0
  93. data/docs/ImportRefusalsRow.md +60 -0
  94. data/docs/InspectionFindingsResponse.md +58 -0
  95. data/docs/InspectionFindingsRow.md +48 -0
  96. data/docs/InspectionsResponse.md +58 -0
  97. data/docs/InspectionsRow.md +60 -0
  98. data/docs/InstitutionalQuarterTotalsResponse.md +58 -0
  99. data/docs/InstitutionalQuarterTotalsRow.md +58 -0
  100. data/docs/LegalEntitiesApi.md +2257 -177
  101. data/docs/LegalEntitiesRecordAttributes.md +8 -0
  102. data/docs/LegalEntitySecFilingsResponse.md +58 -0
  103. data/docs/LegalEntitySecFilingsRow.md +44 -0
  104. data/docs/OrgDisclosureTrendResponse.md +58 -0
  105. data/docs/OrgDisclosureTrendRow.md +62 -0
  106. data/docs/OrgRelationshipsRow.md +1 -1
  107. data/docs/OwnershipPercentagesResponse.md +58 -0
  108. data/docs/OwnershipPercentagesRow.md +74 -0
  109. data/docs/OwnershipSourceCoverageResponse.md +58 -0
  110. data/docs/OwnershipSourceCoverageRow.md +62 -0
  111. data/docs/PdufaDatesRow.md +1 -1
  112. data/docs/ProgramLicensingCandidatesResponse.md +58 -0
  113. data/docs/ProgramLicensingCandidatesRow.md +62 -0
  114. data/docs/ProgramsResponse.md +58 -0
  115. data/docs/ProgramsRow.md +46 -0
  116. data/docs/RareDiseaseGenesResponse.md +58 -0
  117. data/docs/RareDiseaseGenesRow.md +50 -0
  118. data/docs/RareDiseaseHierarchyResponse.md +58 -0
  119. data/docs/RareDiseaseHierarchyRow.md +40 -0
  120. data/docs/RareDiseaseInvestigatorCoverageResponse.md +58 -0
  121. data/docs/RareDiseaseInvestigatorCoverageRow.md +38 -0
  122. data/docs/RareDiseaseInvestigatorsResponse.md +58 -0
  123. data/docs/RareDiseaseInvestigatorsRow.md +56 -0
  124. data/docs/RareDiseaseMappingsResponse.md +58 -0
  125. data/docs/RareDiseaseMappingsRow.md +44 -0
  126. data/docs/RareDiseaseOrganizationsResponse.md +58 -0
  127. data/docs/RareDiseaseOrganizationsRow.md +60 -0
  128. data/docs/RareDiseasePrevalenceResponse.md +58 -0
  129. data/docs/RareDiseasePrevalenceRow.md +62 -0
  130. data/docs/RareDiseaseRarityEvidenceResponse.md +58 -0
  131. data/docs/RareDiseaseRarityEvidenceRow.md +36 -0
  132. data/docs/RareDiseaseRarityResponse.md +58 -0
  133. data/docs/RareDiseaseRarityRow.md +54 -0
  134. data/docs/RareDiseaseReplacementsResponse.md +58 -0
  135. data/docs/RareDiseaseReplacementsRow.md +40 -0
  136. data/docs/RareDiseaseSiteCoverageResponse.md +58 -0
  137. data/docs/RareDiseaseSiteCoverageRow.md +54 -0
  138. data/docs/RareDiseaseSponsorsResponse.md +58 -0
  139. data/docs/RareDiseaseSponsorsRow.md +82 -0
  140. data/docs/RareDiseaseTrialCoverageResponse.md +58 -0
  141. data/docs/RareDiseaseTrialCoverageRow.md +58 -0
  142. data/docs/RareDiseaseTrialSitesResponse.md +58 -0
  143. data/docs/RareDiseaseTrialSitesRow.md +52 -0
  144. data/docs/RareDiseaseTrialsResponse.md +58 -0
  145. data/docs/RareDiseaseTrialsRow.md +90 -0
  146. data/docs/RareDiseasesApi.md +1353 -0
  147. data/docs/RareDiseasesRecord.md +38 -0
  148. data/docs/RareDiseasesRecordAttributes.md +22 -0
  149. data/docs/RareDiseasesResponse.md +58 -0
  150. data/docs/RareDiseasesRow.md +68 -0
  151. data/docs/RecallsResponse.md +58 -0
  152. data/docs/RecallsRow.md +54 -0
  153. data/docs/RwdConductorDeliveryResponse.md +58 -0
  154. data/docs/RwdConductorDeliveryRow.md +74 -0
  155. data/docs/RwdConductorFootprintResponse.md +58 -0
  156. data/docs/RwdConductorFootprintRow.md +40 -0
  157. data/docs/RwdConductorStudiesResponse.md +58 -0
  158. data/docs/RwdConductorStudiesRow.md +42 -0
  159. data/docs/RwdConductorsApi.md +393 -0
  160. data/docs/RwdConductorsRecord.md +38 -0
  161. data/docs/RwdConductorsResponse.md +58 -0
  162. data/docs/RwdConductorsRow.md +72 -0
  163. data/docs/RwdCoverageResponse.md +58 -0
  164. data/docs/RwdCoverageRow.md +52 -0
  165. data/docs/RwdInstitutionsApi.md +153 -0
  166. data/docs/RwdInstitutionsRecord.md +38 -0
  167. data/docs/RwdInstitutionsResponse.md +58 -0
  168. data/docs/RwdInstitutionsRow.md +154 -0
  169. data/docs/RwdNetworksApi.md +153 -0
  170. data/docs/RwdNetworksRecord.md +38 -0
  171. data/docs/RwdNetworksResponse.md +58 -0
  172. data/docs/RwdNetworksRow.md +110 -0
  173. data/docs/RwdRegisterProvenanceResponse.md +58 -0
  174. data/docs/RwdRegisterProvenanceRow.md +74 -0
  175. data/docs/RwdRegistersApi.md +313 -0
  176. data/docs/RwdRegistersRecord.md +38 -0
  177. data/docs/RwdSourceAgeBandsResponse.md +58 -0
  178. data/docs/RwdSourceAgeBandsRow.md +40 -0
  179. data/docs/RwdSourceConditionsResponse.md +58 -0
  180. data/docs/RwdSourceConditionsRow.md +68 -0
  181. data/docs/RwdSourceEtlMappingsResponse.md +58 -0
  182. data/docs/RwdSourceEtlMappingsRow.md +44 -0
  183. data/docs/RwdSourceLinkagesResponse.md +58 -0
  184. data/docs/RwdSourceLinkagesRow.md +64 -0
  185. data/docs/RwdSourceTypesResponse.md +58 -0
  186. data/docs/RwdSourceTypesRow.md +34 -0
  187. data/docs/RwdSourceVocabulariesResponse.md +58 -0
  188. data/docs/RwdSourceVocabulariesRow.md +42 -0
  189. data/docs/RwdSourcesApi.md +713 -0
  190. data/docs/RwdSourcesRecord.md +38 -0
  191. data/docs/RwdSourcesResponse.md +58 -0
  192. data/docs/RwdSourcesRow.md +280 -0
  193. data/docs/RwdStudiesApi.md +553 -0
  194. data/docs/RwdStudiesRecord.md +38 -0
  195. data/docs/RwdStudiesResponse.md +58 -0
  196. data/docs/RwdStudiesRow.md +180 -0
  197. data/docs/RwdStudyConditionsResponse.md +58 -0
  198. data/docs/RwdStudyConditionsRow.md +54 -0
  199. data/docs/RwdStudyDataSourcesResponse.md +58 -0
  200. data/docs/RwdStudyDataSourcesRow.md +54 -0
  201. data/docs/RwdStudyDrugsResponse.md +58 -0
  202. data/docs/RwdStudyDrugsRow.md +50 -0
  203. data/docs/RwdStudyMilestonesResponse.md +58 -0
  204. data/docs/RwdStudyMilestonesRow.md +54 -0
  205. data/docs/RwdWithheldFieldsResponse.md +58 -0
  206. data/docs/RwdWithheldFieldsRow.md +36 -0
  207. data/docs/SbtiCrosscheckResponse.md +58 -0
  208. data/docs/SbtiCrosscheckRow.md +48 -0
  209. data/docs/SecPdufaDatesResponse.md +58 -0
  210. data/docs/SecPdufaDatesRow.md +64 -0
  211. data/docs/SponsorDeliveryResponse.md +58 -0
  212. data/docs/SponsorDeliveryRow.md +52 -0
  213. data/docs/SponsorPatentMentionsResponse.md +58 -0
  214. data/docs/SponsorPatentMentionsRow.md +42 -0
  215. data/docs/SponsorTrialConditionsResponse.md +58 -0
  216. data/docs/SponsorTrialConditionsRow.md +36 -0
  217. data/docs/SponsorTrialDrugsResponse.md +58 -0
  218. data/docs/SponsorTrialDrugsRow.md +34 -0
  219. data/docs/TrialChangesRow.md +5 -1
  220. data/docs/TrialsApi.md +80 -0
  221. data/docs/TrialsRow.md +9 -1
  222. data/docs/UnmatchedProductRevenueResponse.md +58 -0
  223. data/docs/UnmatchedProductRevenueRow.md +80 -0
  224. data/docs/UntitledLettersResponse.md +58 -0
  225. data/docs/UntitledLettersRow.md +44 -0
  226. data/docs/WarningLettersResponse.md +58 -0
  227. data/docs/WarningLettersRow.md +50 -0
  228. data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
  229. data/lib/pharmaobservatory/api/companies_api.rb +3026 -296
  230. data/lib/pharmaobservatory/api/conditions_api.rb +336 -0
  231. data/lib/pharmaobservatory/api/drugs_api.rb +2261 -0
  232. data/lib/pharmaobservatory/api/hospitals_api.rb +413 -0
  233. data/lib/pharmaobservatory/api/legal_entities_api.rb +2376 -192
  234. data/lib/pharmaobservatory/api/rare_diseases_api.rb +1421 -0
  235. data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
  236. data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
  237. data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
  238. data/lib/pharmaobservatory/api/rwd_registers_api.rb +329 -0
  239. data/lib/pharmaobservatory/api/rwd_sources_api.rb +749 -0
  240. data/lib/pharmaobservatory/api/rwd_studies_api.rb +581 -0
  241. data/lib/pharmaobservatory/api/trials_api.rb +84 -0
  242. data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
  243. data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
  244. data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
  245. data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
  246. data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
  247. data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
  248. data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
  249. data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
  250. data/lib/pharmaobservatory/models/brand_companies_response.rb +478 -0
  251. data/lib/pharmaobservatory/models/brand_companies_row.rb +401 -0
  252. data/lib/pharmaobservatory/models/brand_revenue_response.rb +478 -0
  253. data/lib/pharmaobservatory/models/brand_revenue_row.rb +454 -0
  254. data/lib/pharmaobservatory/models/catalysts_response.rb +478 -0
  255. data/lib/pharmaobservatory/models/catalysts_row.rb +623 -0
  256. data/lib/pharmaobservatory/models/clia_certificates_response.rb +478 -0
  257. data/lib/pharmaobservatory/models/clia_certificates_row.rb +568 -0
  258. data/lib/pharmaobservatory/models/companies_record_attributes.rb +13 -4
  259. data/lib/pharmaobservatory/models/company_assets_row.rb +24 -2
  260. data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
  261. data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
  262. data/lib/pharmaobservatory/models/company_funding_events_row.rb +12 -1
  263. data/lib/pharmaobservatory/models/company_programs_row.rb +24 -2
  264. data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
  265. data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
  266. data/lib/pharmaobservatory/models/company_trial_geography_response.rb +478 -0
  267. data/lib/pharmaobservatory/models/company_trial_geography_row.rb +410 -0
  268. data/lib/pharmaobservatory/models/company_trial_sites_response.rb +478 -0
  269. data/lib/pharmaobservatory/models/company_trial_sites_row.rb +410 -0
  270. data/lib/pharmaobservatory/models/cro_footprint_response.rb +478 -0
  271. data/lib/pharmaobservatory/models/cro_footprint_row.rb +311 -0
  272. data/lib/pharmaobservatory/models/cro_trials_response.rb +478 -0
  273. data/lib/pharmaobservatory/models/cro_trials_row.rb +381 -0
  274. data/lib/pharmaobservatory/models/debarments_response.rb +478 -0
  275. data/lib/pharmaobservatory/models/debarments_row.rb +366 -0
  276. data/lib/pharmaobservatory/models/drug_approvals_response.rb +478 -0
  277. data/lib/pharmaobservatory/models/drug_approvals_row.rb +278 -0
  278. data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +478 -0
  279. data/lib/pharmaobservatory/models/drug_asp_codes_row.rb +278 -0
  280. data/lib/pharmaobservatory/models/drug_brands_response.rb +478 -0
  281. data/lib/pharmaobservatory/models/drug_brands_row.rb +454 -0
  282. data/lib/pharmaobservatory/models/drug_combinations_response.rb +478 -0
  283. data/lib/pharmaobservatory/models/drug_combinations_row.rb +300 -0
  284. data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +478 -0
  285. data/lib/pharmaobservatory/models/drug_declared_patents_row.rb +447 -0
  286. data/lib/pharmaobservatory/models/drug_label_safety_response.rb +478 -0
  287. data/lib/pharmaobservatory/models/drug_label_safety_row.rb +300 -0
  288. data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +478 -0
  289. data/lib/pharmaobservatory/models/drug_medicare_spend_row.rb +280 -0
  290. data/lib/pharmaobservatory/models/drug_patent_cliff_row.rb +13 -2
  291. data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +478 -0
  292. data/lib/pharmaobservatory/models/drug_patent_mentions_row.rb +278 -0
  293. data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +478 -0
  294. data/lib/pharmaobservatory/models/drug_patent_owners_row.rb +357 -0
  295. data/lib/pharmaobservatory/models/drug_pricing_response.rb +478 -0
  296. data/lib/pharmaobservatory/models/drug_pricing_row.rb +300 -0
  297. data/lib/pharmaobservatory/models/drug_recalls_response.rb +478 -0
  298. data/lib/pharmaobservatory/models/drug_recalls_row.rb +311 -0
  299. data/lib/pharmaobservatory/models/drug_regulatory_response.rb +478 -0
  300. data/lib/pharmaobservatory/models/drug_regulatory_row.rb +333 -0
  301. data/lib/pharmaobservatory/models/drug_sites_response.rb +478 -0
  302. data/lib/pharmaobservatory/models/drug_sites_row.rb +278 -0
  303. data/lib/pharmaobservatory/models/drug_targets_response.rb +478 -0
  304. data/lib/pharmaobservatory/models/drug_targets_row.rb +324 -0
  305. data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +478 -0
  306. data/lib/pharmaobservatory/models/drug_trial_conditions_row.rb +289 -0
  307. data/lib/pharmaobservatory/models/drug_trials_response.rb +478 -0
  308. data/lib/pharmaobservatory/models/drug_trials_row.rb +445 -0
  309. data/lib/pharmaobservatory/models/drug_variants_response.rb +478 -0
  310. data/lib/pharmaobservatory/models/drug_variants_row.rb +333 -0
  311. data/lib/pharmaobservatory/models/drugs_record.rb +385 -0
  312. data/lib/pharmaobservatory/models/drugs_record_attributes.rb +229 -0
  313. data/lib/pharmaobservatory/models/drugs_response.rb +478 -0
  314. data/lib/pharmaobservatory/models/drugs_row.rb +581 -0
  315. data/lib/pharmaobservatory/models/enforcement_events_response.rb +478 -0
  316. data/lib/pharmaobservatory/models/enforcement_events_row.rb +476 -0
  317. data/lib/pharmaobservatory/models/gxp_facilities_response.rb +478 -0
  318. data/lib/pharmaobservatory/models/gxp_facilities_row.rb +1089 -0
  319. data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +478 -0
  320. data/lib/pharmaobservatory/models/hospital_beds_yearly_row.rb +278 -0
  321. data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +478 -0
  322. data/lib/pharmaobservatory/models/hospital_facility_changes_row.rb +289 -0
  323. data/lib/pharmaobservatory/models/hospitals_record.rb +385 -0
  324. data/lib/pharmaobservatory/models/hospitals_response.rb +478 -0
  325. data/lib/pharmaobservatory/models/hospitals_row.rb +344 -0
  326. data/lib/pharmaobservatory/models/import_refusals_response.rb +478 -0
  327. data/lib/pharmaobservatory/models/import_refusals_row.rb +454 -0
  328. data/lib/pharmaobservatory/models/inspection_findings_response.rb +478 -0
  329. data/lib/pharmaobservatory/models/inspection_findings_row.rb +388 -0
  330. data/lib/pharmaobservatory/models/inspections_response.rb +478 -0
  331. data/lib/pharmaobservatory/models/inspections_row.rb +454 -0
  332. data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +478 -0
  333. data/lib/pharmaobservatory/models/institutional_quarter_totals_row.rb +443 -0
  334. data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +37 -1
  335. data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
  336. data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
  337. data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
  338. data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
  339. data/lib/pharmaobservatory/models/org_relationships_row.rb +1 -1
  340. data/lib/pharmaobservatory/models/ownership_percentages_response.rb +478 -0
  341. data/lib/pharmaobservatory/models/ownership_percentages_row.rb +531 -0
  342. data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
  343. data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
  344. data/lib/pharmaobservatory/models/pdufa_dates_row.rb +1 -1
  345. data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +478 -0
  346. data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +467 -0
  347. data/lib/pharmaobservatory/models/programs_response.rb +478 -0
  348. data/lib/pharmaobservatory/models/programs_row.rb +377 -0
  349. data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +478 -0
  350. data/lib/pharmaobservatory/models/rare_disease_genes_row.rb +399 -0
  351. data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +478 -0
  352. data/lib/pharmaobservatory/models/rare_disease_hierarchy_row.rb +344 -0
  353. data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +478 -0
  354. data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_row.rb +333 -0
  355. data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +478 -0
  356. data/lib/pharmaobservatory/models/rare_disease_investigators_row.rb +436 -0
  357. data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +478 -0
  358. data/lib/pharmaobservatory/models/rare_disease_mappings_row.rb +366 -0
  359. data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +478 -0
  360. data/lib/pharmaobservatory/models/rare_disease_organizations_row.rb +454 -0
  361. data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +478 -0
  362. data/lib/pharmaobservatory/models/rare_disease_prevalence_row.rb +465 -0
  363. data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +478 -0
  364. data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_row.rb +322 -0
  365. data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +478 -0
  366. data/lib/pharmaobservatory/models/rare_disease_rarity_row.rb +421 -0
  367. data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +478 -0
  368. data/lib/pharmaobservatory/models/rare_disease_replacements_row.rb +344 -0
  369. data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +478 -0
  370. data/lib/pharmaobservatory/models/rare_disease_site_coverage_row.rb +421 -0
  371. data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +478 -0
  372. data/lib/pharmaobservatory/models/rare_disease_sponsors_row.rb +575 -0
  373. data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +478 -0
  374. data/lib/pharmaobservatory/models/rare_disease_trial_coverage_row.rb +449 -0
  375. data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +478 -0
  376. data/lib/pharmaobservatory/models/rare_disease_trial_sites_row.rb +412 -0
  377. data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +478 -0
  378. data/lib/pharmaobservatory/models/rare_disease_trials_row.rb +623 -0
  379. data/lib/pharmaobservatory/models/rare_diseases_record.rb +385 -0
  380. data/lib/pharmaobservatory/models/rare_diseases_record_attributes.rb +238 -0
  381. data/lib/pharmaobservatory/models/rare_diseases_response.rb +478 -0
  382. data/lib/pharmaobservatory/models/rare_diseases_row.rb +500 -0
  383. data/lib/pharmaobservatory/models/recalls_response.rb +478 -0
  384. data/lib/pharmaobservatory/models/recalls_row.rb +421 -0
  385. data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
  386. data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
  387. data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
  388. data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
  389. data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
  390. data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
  391. data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
  392. data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
  393. data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
  394. data/lib/pharmaobservatory/models/rwd_coverage_response.rb +478 -0
  395. data/lib/pharmaobservatory/models/rwd_coverage_row.rb +410 -0
  396. data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
  397. data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
  398. data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
  399. data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
  400. data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
  401. data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
  402. data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +478 -0
  403. data/lib/pharmaobservatory/models/rwd_register_provenance_row.rb +531 -0
  404. data/lib/pharmaobservatory/models/rwd_registers_record.rb +385 -0
  405. data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +478 -0
  406. data/lib/pharmaobservatory/models/rwd_source_age_bands_row.rb +344 -0
  407. data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +478 -0
  408. data/lib/pharmaobservatory/models/rwd_source_conditions_row.rb +502 -0
  409. data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +478 -0
  410. data/lib/pharmaobservatory/models/rwd_source_etl_mappings_row.rb +366 -0
  411. data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +478 -0
  412. data/lib/pharmaobservatory/models/rwd_source_linkages_row.rb +476 -0
  413. data/lib/pharmaobservatory/models/rwd_source_types_response.rb +478 -0
  414. data/lib/pharmaobservatory/models/rwd_source_types_row.rb +311 -0
  415. data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +478 -0
  416. data/lib/pharmaobservatory/models/rwd_source_vocabularies_row.rb +355 -0
  417. data/lib/pharmaobservatory/models/rwd_sources_record.rb +385 -0
  418. data/lib/pharmaobservatory/models/rwd_sources_response.rb +478 -0
  419. data/lib/pharmaobservatory/models/rwd_sources_row.rb +1674 -0
  420. data/lib/pharmaobservatory/models/rwd_studies_record.rb +385 -0
  421. data/lib/pharmaobservatory/models/rwd_studies_response.rb +478 -0
  422. data/lib/pharmaobservatory/models/rwd_studies_row.rb +1138 -0
  423. data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +478 -0
  424. data/lib/pharmaobservatory/models/rwd_study_conditions_row.rb +421 -0
  425. data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +478 -0
  426. data/lib/pharmaobservatory/models/rwd_study_data_sources_row.rb +423 -0
  427. data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +478 -0
  428. data/lib/pharmaobservatory/models/rwd_study_drugs_row.rb +401 -0
  429. data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +478 -0
  430. data/lib/pharmaobservatory/models/rwd_study_milestones_row.rb +421 -0
  431. data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +478 -0
  432. data/lib/pharmaobservatory/models/rwd_withheld_fields_row.rb +322 -0
  433. data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
  434. data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
  435. data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +478 -0
  436. data/lib/pharmaobservatory/models/sec_pdufa_dates_row.rb +476 -0
  437. data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
  438. data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
  439. data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
  440. data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
  441. data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
  442. data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
  443. data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
  444. data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
  445. data/lib/pharmaobservatory/models/trial_changes_row.rb +24 -2
  446. data/lib/pharmaobservatory/models/trials_row.rb +47 -3
  447. data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +478 -0
  448. data/lib/pharmaobservatory/models/unmatched_product_revenue_row.rb +564 -0
  449. data/lib/pharmaobservatory/models/untitled_letters_response.rb +478 -0
  450. data/lib/pharmaobservatory/models/untitled_letters_row.rb +366 -0
  451. data/lib/pharmaobservatory/models/warning_letters_response.rb +478 -0
  452. data/lib/pharmaobservatory/models/warning_letters_row.rb +399 -0
  453. data/lib/pharmaobservatory/version.rb +1 -1
  454. data/lib/pharmaobservatory.rb +210 -0
  455. metadata +422 -2
@@ -4,6 +4,10 @@
4
4
 
5
5
  | Name | Type | Description | Notes |
6
6
  | ---- | ---- | ----------- | ----- |
7
+ | **legal_entity_sec_filings** | [**LegalEntitySecFilingsRow**](LegalEntitySecFilingsRow.md) | | [optional] |
8
+ | **ownership_percentages** | [**OwnershipPercentagesRow**](OwnershipPercentagesRow.md) | | [optional] |
9
+ | **sbti_crosscheck** | [**SbtiCrosscheckRow**](SbtiCrosscheckRow.md) | | [optional] |
10
+ | **sponsor_delivery** | [**SponsorDeliveryRow**](SponsorDeliveryRow.md) | | [optional] |
7
11
  | **sponsor_recruitment_duration** | [**SponsorRecruitmentDurationRow**](SponsorRecruitmentDurationRow.md) | | [optional] |
8
12
 
9
13
  ## Example
@@ -12,6 +16,10 @@
12
16
  require 'pharmaobservatory'
13
17
 
14
18
  instance = PharmaObservatory::LegalEntitiesRecordAttributes.new(
19
+ legal_entity_sec_filings: null,
20
+ ownership_percentages: null,
21
+ sbti_crosscheck: null,
22
+ sponsor_delivery: null,
15
23
  sponsor_recruitment_duration: null
16
24
  )
17
25
  ```
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::LegalEntitySecFilingsResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<LegalEntitySecFilingsRow>**](LegalEntitySecFilingsRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::LegalEntitySecFilingsResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,44 @@
1
+ # PharmaObservatory::LegalEntitySecFilingsRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **org_id** | **String** | Legal-entity level: the SEC filer organization record. | [optional] |
8
+ | **org_name** | **String** | Display name of the filer organization record. | [optional] |
9
+ | **company_id** | **String** | Company level: the company the filer belongs to (null when unresolved). | [optional] |
10
+ | **company_name** | **String** | Display name of the filer's company. | [optional] |
11
+ | **group_id** | **String** | Group level: the filer's current ultimate parent company; a root company's group is itself. | [optional] |
12
+ | **group_name** | **String** | Display name of the filer's group. | [optional] |
13
+ | **edgar_cik** | **String** | The filer's 10-digit SEC Central Index Key (CIK). | [optional] |
14
+ | **jurisdiction_of_inc** | **String** | The jurisdiction of incorporation as the latest filing states it (a US state or a country, free text); null when blank. | [optional] |
15
+ | **entity_type** | **String** | The entity type the latest filing states (Corporation, Limited Liability Company, Limited Partnership, General Partnership, Business Trust or Other); null when blank. | [optional] |
16
+ | **entity_type_other_desc** | **String** | The filer's free-text description when it ticked entity type Other. | [optional] |
17
+ | **year_of_inc_band** | **String** | The filing's year-of-incorporation choice (Over Five Years Ago, Within Last Five Years or Yet to Be Formed); null when blank. | [optional] |
18
+ | **year_of_inc** | **Integer** | The year of incorporation when the filing gives a four-digit year. | [optional] |
19
+ | **industry_group_types** | **Array<String>** | The industry groups the filer's in-scope filings name. | [optional] |
20
+ | **previous_names** | **Array<String>** | Earlier names the filer states, other than its current name. | [optional] |
21
+
22
+ ## Example
23
+
24
+ ```ruby
25
+ require 'pharmaobservatory'
26
+
27
+ instance = PharmaObservatory::LegalEntitySecFilingsRow.new(
28
+ org_id: null,
29
+ org_name: null,
30
+ company_id: null,
31
+ company_name: null,
32
+ group_id: null,
33
+ group_name: null,
34
+ edgar_cik: null,
35
+ jurisdiction_of_inc: null,
36
+ entity_type: null,
37
+ entity_type_other_desc: null,
38
+ year_of_inc_band: null,
39
+ year_of_inc: null,
40
+ industry_group_types: null,
41
+ previous_names: null
42
+ )
43
+ ```
44
+
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::OrgDisclosureTrendResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<OrgDisclosureTrendRow>**](OrgDisclosureTrendRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::OrgDisclosureTrendResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,62 @@
1
+ # PharmaObservatory::OrgDisclosureTrendRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **org_id** | **String** | Legal-entity level: the organization record of the SEC registrant that filed. | [optional] |
8
+ | **org_name** | **String** | Display name of the filing organization record. | [optional] |
9
+ | **company_id** | **String** | Company level: the company the filing organization belongs to (null when unresolved). | [optional] |
10
+ | **company_name** | **String** | Display name of the filing organization's company. | [optional] |
11
+ | **group_id** | **String** | Group level: the filing organization's current ultimate parent company; a root company's group is itself. | [optional] |
12
+ | **group_name** | **String** | Display name of the filing organization's group. | [optional] |
13
+ | **reporting_year** | **Integer** | The fiscal year the filing reports. | [optional] |
14
+ | **reporting_company** | **String** | The company name as the filing states it. | [optional] |
15
+ | **cik** | **String** | The registrant's SEC Central Index Key (CIK). | [optional] |
16
+ | **ticker** | **String** | The stock ticker the filing states. | [optional] |
17
+ | **board_pct_women** | **Float** | Women's share of the board, as the filing states it. | [optional] |
18
+ | **workforce_pct_women** | **Float** | Women's share of the workforce. | [optional] |
19
+ | **leadership_pct_women** | **Float** | Women's share of leadership roles. | [optional] |
20
+ | **workforce_pct_underrepresented** | **Float** | Share of the workforce from underrepresented groups. | [optional] |
21
+ | **gender_pay_gap_pct** | **Float** | The stated gender pay gap. | [optional] |
22
+ | **has_dei_targets** | **Boolean** | Whether the filing states diversity, equity and inclusion targets. | [optional] |
23
+ | **has_net_zero_target** | **Boolean** | Whether the filing states a net-zero target. | [optional] |
24
+ | **net_zero_target_year** | **Integer** | The year of the net-zero target. | [optional] |
25
+ | **reduction_pct** | **Float** | The emissions reduction the filing commits to. | [optional] |
26
+ | **sbti_status_claimed** | **String** | The Science Based Targets initiative (SBTi) status the filing claims for itself (a claim in the filing, not the SBTi list). | [optional] |
27
+ | **target_temperature_claimed** | **String** | The warming limit the filing says its targets align with. | [optional] |
28
+ | **climate_document_id** | **String** | The filing document the climate measures were extracted from. | [optional] |
29
+ | **diversity_document_id** | **String** | The filing document the diversity measures were extracted from. | [optional] |
30
+
31
+ ## Example
32
+
33
+ ```ruby
34
+ require 'pharmaobservatory'
35
+
36
+ instance = PharmaObservatory::OrgDisclosureTrendRow.new(
37
+ org_id: null,
38
+ org_name: null,
39
+ company_id: null,
40
+ company_name: null,
41
+ group_id: null,
42
+ group_name: null,
43
+ reporting_year: null,
44
+ reporting_company: null,
45
+ cik: null,
46
+ ticker: null,
47
+ board_pct_women: null,
48
+ workforce_pct_women: null,
49
+ leadership_pct_women: null,
50
+ workforce_pct_underrepresented: null,
51
+ gender_pay_gap_pct: null,
52
+ has_dei_targets: null,
53
+ has_net_zero_target: null,
54
+ net_zero_target_year: null,
55
+ reduction_pct: null,
56
+ sbti_status_claimed: null,
57
+ target_temperature_claimed: null,
58
+ climate_document_id: null,
59
+ diversity_document_id: null
60
+ )
61
+ ```
62
+
@@ -29,7 +29,7 @@
29
29
  | **last_observed_at** | **Time** | When the latest of the edge's records was observed in the source. | [optional] |
30
30
  | **license_name** | **String** | The licence of the source behind the edge. | [optional] |
31
31
  | **attribution** | **String** | The credit line the source requires for the edge. Show it wherever the edge is shown: the Charity Commission and UK Research and Innovation edges require it under the Open Government Licence v3.0. | [optional] |
32
- | **restriction_tier** | **String** | Always none: every source behind these edges is open, and a test on the source assertions reports any restricted source that is ever added. | [optional] |
32
+ | **restriction_tier** | **String** | The tier vocabulary is none or licensable. Every row here is none: every source behind these edges is open, and a test on the source assertions reports any restricted source that is ever added. | [optional] |
33
33
 
34
34
  ## Example
35
35
 
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::OwnershipPercentagesResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<OwnershipPercentagesRow>**](OwnershipPercentagesRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::OwnershipPercentagesResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,74 @@
1
+ # PharmaObservatory::OwnershipPercentagesRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **subject_org_id** | **String** | Legal-entity level: the subject organization's record, a resolution root (the identity every ownership dataset keys on). One row per organization; an insider row with no organization has no row here. | [optional] |
8
+ | **subject_company_id** | **String** | Company level: the subject organization's company (null when the organization does not resolve to a company). | [optional] |
9
+ | **subject_company_name** | **String** | Display name of the subject organization's company. | [optional] |
10
+ | **subject_group_id** | **String** | Group level: the subject organization's current ultimate parent company; a root company's group is itself. | [optional] |
11
+ | **subject_group_name** | **String** | Display name of the subject organization's group. | [optional] |
12
+ | **any_ownership_source** | **Boolean** | True when an insider row or a Form 13F quarter exists for the organization. | [optional] |
13
+ | **shares_outstanding_state** | **String** | reported when the organization has a cover-page share count on file, not_reported when it has none (then no percentage is taken and the share figures are shown instead). | [optional] |
14
+ | **shares_outstanding** | **Float** | The denominator both percentages divide into: the latest cover-page share count (dei:EntityCommonStockSharesOutstanding) from an annual form. It is measured on the filing's cover date, 0 to 3 months after the fiscal period end, and the cover date is not published, so its vintage is the fiscal year in shares_outstanding_fy. | [optional] |
15
+ | **shares_outstanding_fy** | **Integer** | The fiscal year of the filing the share count comes from. | [optional] |
16
+ | **shares_outstanding_concept** | **String** | The XBRL (eXtensible Business Reporting Language) concept the share count is read from. Always dei:EntityCommonStockSharesOutstanding. | [optional] |
17
+ | **insider_state** | **String** | How the insider figure was reached. reported: The sum of the current non-derivative balance each reporting owner last filed on a Form 3, 4 or 5, divided by the share count on file. no_insider_filing: No Form 3, 4 or 5 in our data names an insider of this company. That is a statement about coverage, not a statement that insiders hold nothing. all_positions_closed: Every insider position on file has been reported closed. This is a filed zero, not missing data. derivative_only: The insiders on file hold only derivative positions (options and similar), which are not outstanding shares. This is a filed zero, not missing data. no_denominator: No percentage: this company's SEC filings in our data carry no cover-page share count, so there is no denominator to divide by. The share count on file is shown instead. not_computable: No percentage is taken here. The reported share total is given instead, with the reason no ratio is taken. | [optional] |
18
+ | **insider_reason** | **String** | Why an insider ratio was not taken when insider_state is not_computable. denominator_stale: The share count on file is more than two years older than the positions it would be divided into, so the ratio would not describe this company. exceeds_shares_outstanding: The insider total on file is larger than the company's whole share count, which is arithmetically impossible for a single source and means the filings behind it have not consolidated correctly. Null otherwise. | [optional] |
19
+ | **insider_percent** | **Float** | The share of shares outstanding held by Form 3, 4 and 5 insiders (insider_shares divided by shares_outstanding, times 100, unrounded); null unless insider_state is reported. | [optional] |
20
+ | **insider_shares** | **Float** | The sum of the current non-derivative balance each reporting insider last filed. A ceased or options-only insider adds nothing to it. Null when no insider holds standing shares. | [optional] |
21
+ | **insider_owner_count** | **Integer** | Insiders on file for the organization (0 when none). | [optional] |
22
+ | **insider_standing_owner_count** | **Integer** | Insiders with a positive standing equity balance, the only population insider_shares describes. | [optional] |
23
+ | **insider_closed_owner_count** | **Integer** | Insiders whose standing equity balance is zero or absent: closed positions plus options-only insiders. | [optional] |
24
+ | **insider_derivative_only_owner_count** | **Integer** | Of the closed insiders, those whose only remaining positions are derivatives (options and similar), which are not outstanding shares. | [optional] |
25
+ | **insider_last_filing_date** | **Date** | The latest filing date among the organization's insider rows. | [optional] |
26
+ | **institutional_state** | **String** | How the institutional figure was reached. reported: Every position reported on Form 13F for the quarter shown, summed once per filing manager, against the same share count as the insider figure. exceeds_outstanding: Reported positions exceed the shares outstanding on file. Shown as filed. implausible: No percentage: reported positions exceed 1.5 times the shares outstanding on file, which indicates a corporate action or a denominator mismatch rather than ownership. no_13f_issuer: No Form 13F issuer resolved to this company in any quarter. Positions are reported against a SECURITY, so this is a statement about the CUSIP-to-company bridge, not about institutional interest. no_reference_period: No manager reported this company for the most recent fully-reported quarter. Positions in earlier quarters are on file and are reported per manager, but a manager whose newest filing is for an older quarter is not a current holder and is not counted here. no_reference_shares: No manager reported an equity position in this company for the most recent fully-reported quarter. Only options, debt or non-equity issues were reported, and none of those is a share count. no_denominator: No percentage: this company's SEC filings in our data carry no cover-page share count, so there is no denominator to divide by. The reported share total is shown instead. not_computable: No percentage is taken here. The reported share total is given instead, with the reason no ratio is taken. | [optional] |
27
+ | **institutional_reason** | **String** | Why an institutional ratio was not taken when institutional_state is not_computable. denominator_stale: The share count on file is more than two years older than the positions it would be divided into, so the ratio would not describe this company. Null otherwise. | [optional] |
28
+ | **institutional_percent** | **Float** | The share of shares outstanding under reported institutional discretion at the reference quarter (institutional_shares_reported divided by shares_outstanding, times 100, unrounded, as filed and never capped); null unless institutional_state is reported or exceeds_outstanding. | [optional] |
29
+ | **institutional_shares_reported** | **Float** | The shares reported on Form 13F at the reference quarter, counted equity positions only, summed once per filing manager. Null when the organization has no reference-quarter row. | [optional] |
30
+ | **institutional_manager_count** | **Integer** | Managers reporting a counted equity position at the reference quarter (0 when there is no reference-quarter row). | [optional] |
31
+ | **institutional_report_period** | **Date** | The reference quarter end the institutional figure is measured at: the most recent quarter in which at least 80 percent of the prior quarter's filing managers had filed. | [optional] |
32
+ | **institutional_shares_otr** | **Float** | Of institutional_shares_reported, the shares under other (OTR) discretion. | [optional] |
33
+ | **institutional_shares_excluded_non_equity_issue** | **Float** | Shares reported against convertible notes, debt and preferred issues at the reference quarter, excluded from institutional_shares_reported. | [optional] |
34
+ | **institutional_equity_cusip_count** | **Integer** | Distinct equity CUSIPs (Committee on Uniform Securities Identification Procedures identifiers) counted at the reference quarter (0 when there is no reference-quarter row). | [optional] |
35
+ | **institutional_latest_filing_date** | **Date** | The latest Form 13F filing date among the reference quarter's positions. | [optional] |
36
+
37
+ ## Example
38
+
39
+ ```ruby
40
+ require 'pharmaobservatory'
41
+
42
+ instance = PharmaObservatory::OwnershipPercentagesRow.new(
43
+ subject_org_id: null,
44
+ subject_company_id: null,
45
+ subject_company_name: null,
46
+ subject_group_id: null,
47
+ subject_group_name: null,
48
+ any_ownership_source: null,
49
+ shares_outstanding_state: null,
50
+ shares_outstanding: null,
51
+ shares_outstanding_fy: null,
52
+ shares_outstanding_concept: null,
53
+ insider_state: null,
54
+ insider_reason: null,
55
+ insider_percent: null,
56
+ insider_shares: null,
57
+ insider_owner_count: null,
58
+ insider_standing_owner_count: null,
59
+ insider_closed_owner_count: null,
60
+ insider_derivative_only_owner_count: null,
61
+ insider_last_filing_date: null,
62
+ institutional_state: null,
63
+ institutional_reason: null,
64
+ institutional_percent: null,
65
+ institutional_shares_reported: null,
66
+ institutional_manager_count: null,
67
+ institutional_report_period: null,
68
+ institutional_shares_otr: null,
69
+ institutional_shares_excluded_non_equity_issue: null,
70
+ institutional_equity_cusip_count: null,
71
+ institutional_latest_filing_date: null
72
+ )
73
+ ```
74
+
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::OwnershipSourceCoverageResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<OwnershipSourceCoverageRow>**](OwnershipSourceCoverageRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::OwnershipSourceCoverageResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,62 @@
1
+ # PharmaObservatory::OwnershipSourceCoverageRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **source_class** | **String** | The ownership source class (for example sec_def_14a for proxy statements, sec_form_adv for Form ADV). | [optional] |
8
+ | **subject_source_ref** | **String** | The subject as the source names it: the source's own reference for the owned company. | [optional] |
9
+ | **subject_name** | **String** | The subject's name as filed. | [optional] |
10
+ | **subject_org_id** | **String** | Legal-entity level: the organization record of the subject. | [optional] |
11
+ | **subject_company_id** | **String** | Company level: the company the subject belongs to (null when unresolved). | [optional] |
12
+ | **subject_company_name** | **String** | Display name of the subject's company. | [optional] |
13
+ | **subject_group_id** | **String** | Group level: the subject's current ultimate parent company; a root company's group is itself. | [optional] |
14
+ | **subject_group_name** | **String** | Display name of the subject's group. | [optional] |
15
+ | **source_system** | **String** | The system the source class is read from (for example sec_edgar). | [optional] |
16
+ | **source_load_state** | **String** | The whole-source state: loaded, served_by_dedicated_mart (13F is served by the institutional holdings datasets), no_documents_ingested or source_not_ingested. | [optional] |
17
+ | **source_documents_ingested** | **Integer** | Documents the whole source has ingested. | [optional] |
18
+ | **coverage_state** | **String** | What the source read about this subject: reported, no_reportable_owner, extraction_abstained or read_no_owner. | [optional] |
19
+ | **documents_ingested** | **Integer** | Documents the source ingested about this subject. | [optional] |
20
+ | **observations** | **Integer** | Ownership observations the source recorded about this subject. | [optional] |
21
+ | **current_edges** | **Integer** | Ownership relationships that currently stand. | [optional] |
22
+ | **owners_distinct** | **Integer** | Distinct owners the source named for this subject. | [optional] |
23
+ | **owners_unresolved** | **Integer** | Named owners that did not resolve to an organization or investor. | [optional] |
24
+ | **no_reportable_owner_statements** | **Integer** | Filings that positively stated the subject has no reportable owner. | [optional] |
25
+ | **extraction_abstained** | **Integer** | Documents on which the extractor abstained. | [optional] |
26
+ | **last_filing_date** | **Date** | The latest filing date the source holds for this subject. | [optional] |
27
+ | **max_as_of_date** | **Date** | The latest as-of date among the subject's observations. | [optional] |
28
+ | **source_license** | **String** | The licence of the source. | [optional] |
29
+ | **attribution** | **String** | The credit line for the source. | [optional] |
30
+
31
+ ## Example
32
+
33
+ ```ruby
34
+ require 'pharmaobservatory'
35
+
36
+ instance = PharmaObservatory::OwnershipSourceCoverageRow.new(
37
+ source_class: null,
38
+ subject_source_ref: null,
39
+ subject_name: null,
40
+ subject_org_id: null,
41
+ subject_company_id: null,
42
+ subject_company_name: null,
43
+ subject_group_id: null,
44
+ subject_group_name: null,
45
+ source_system: null,
46
+ source_load_state: null,
47
+ source_documents_ingested: null,
48
+ coverage_state: null,
49
+ documents_ingested: null,
50
+ observations: null,
51
+ current_edges: null,
52
+ owners_distinct: null,
53
+ owners_unresolved: null,
54
+ no_reportable_owner_statements: null,
55
+ extraction_abstained: null,
56
+ last_filing_date: null,
57
+ max_as_of_date: null,
58
+ source_license: null,
59
+ attribution: null
60
+ )
61
+ ```
62
+
@@ -16,7 +16,7 @@
16
16
  | **event_category** | **String** | Event category (pdufa, adcomm and so on). | [optional] |
17
17
  | **drug_name** | **String** | The drug name as filed. | [optional] |
18
18
  | **drug_id** | **String** | The drug key. | [optional] |
19
- | **molecule_id** | **String** | The molecule key. | [optional] |
19
+ | **molecule_id** | **String** | The molecule key, the resolved drug of the calendar entry and the entry key for the drugs object type (null when the drug name did not resolve to a drug). | [optional] |
20
20
  | **sponsor_name** | **String** | The sponsor name as filed. | [optional] |
21
21
  | **sponsor_org_id** | **String** | Legal-entity level: the organization record the sponsor resolved to (null when unresolved). | [optional] |
22
22
  | **sponsor_company_id** | **String** | Company level: the company the sponsor belongs to (null when unresolved). | [optional] |
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::ProgramLicensingCandidatesResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<ProgramLicensingCandidatesRow>**](ProgramLicensingCandidatesRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::ProgramLicensingCandidatesResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,62 @@
1
+ # PharmaObservatory::ProgramLicensingCandidatesRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **sponsor_org_id** | **String** | Legal-entity level: the lead sponsor's organization record. | [optional] |
8
+ | **sponsor_name** | **String** | The sponsor's organization name. | [optional] |
9
+ | **sponsor_company_id** | **String** | Company level: the sponsor's company (null when unresolved). | [optional] |
10
+ | **sponsor_company_name** | **String** | Display name of the sponsor's company. | [optional] |
11
+ | **sponsor_group_id** | **String** | Group level: the sponsor's current ultimate parent; a root's group is itself. | [optional] |
12
+ | **sponsor_group_name** | **String** | Display name of the sponsor's group. | [optional] |
13
+ | **drug_id** | **String** | The drug key. | [optional] |
14
+ | **drug_name** | **String** | The drug's name. | [optional] |
15
+ | **condition_id** | **String** | The condition key, a MeSH (Medical Subject Headings) descriptor id (D followed by six to nine digits). | [optional] |
16
+ | **condition_name** | **String** | The condition's name. | [optional] |
17
+ | **condition_ancestor_ids** | **Array<String>** | Every MeSH descriptor id at or above the condition in the tree, the condition itself included. Filter a subtree with = ANY. | [optional] |
18
+ | **max_phase** | **Integer** | Highest phase reached on the 0 to 4 scale: 0 not reported, 1 through 4 for phase 1 through phase 4 (4 is marketed); a split phase folds up to its higher phase. | [optional] |
19
+ | **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
20
+ | **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
21
+ | **n_trials** | **Integer** | Lead-sponsored trials in the program. | [optional] |
22
+ | **n_active** | **Integer** | Of those, trials in an active status. | [optional] |
23
+ | **last_year** | **Integer** | Latest trial start year. | [optional] |
24
+ | **last_update_year** | **Integer** | Year the program's most recently updated trial record was posted. | [optional] |
25
+ | **withdrawn** | **Boolean** | True when the drug has been withdrawn. | [optional] |
26
+ | **cause_name** | **String** | The Global Burden of Disease cause matched to the condition. | [optional] |
27
+ | **dalys_millions** | **Float** | Global disability-adjusted life years for the matched cause, in millions. | [optional] |
28
+ | **deaths_millions** | **Float** | Global deaths for the matched cause, in millions. | [optional] |
29
+ | **druggability** | **Integer** | Druggability class of the matched cause: 1 highly druggable, 2 druggable, 3 challenging, 4 very challenging. | [optional] |
30
+
31
+ ## Example
32
+
33
+ ```ruby
34
+ require 'pharmaobservatory'
35
+
36
+ instance = PharmaObservatory::ProgramLicensingCandidatesRow.new(
37
+ sponsor_org_id: null,
38
+ sponsor_name: null,
39
+ sponsor_company_id: null,
40
+ sponsor_company_name: null,
41
+ sponsor_group_id: null,
42
+ sponsor_group_name: null,
43
+ drug_id: null,
44
+ drug_name: null,
45
+ condition_id: null,
46
+ condition_name: null,
47
+ condition_ancestor_ids: null,
48
+ max_phase: null,
49
+ max_phase_label: null,
50
+ max_phase_fine_rank: null,
51
+ n_trials: null,
52
+ n_active: null,
53
+ last_year: null,
54
+ last_update_year: null,
55
+ withdrawn: null,
56
+ cause_name: null,
57
+ dalys_millions: null,
58
+ deaths_millions: null,
59
+ druggability: null
60
+ )
61
+ ```
62
+